Does the Entire Uterus Need to be Treated in Cancer of the Cervix? Role of Adaptive Brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3, 2010, Pages 704-712

  Anker, Christopher J ^a   Cachoeira, Charles V ^a   Boucher, Kenneth M ^a   Rankin, Jim ^a   Gaffney, David K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive brachytherapy; Cervical carcinoma; Local control; Pattern of recurrence; Toxicity

Indexed keywords

BRACHYTHERAPY; CERVICAL CANCERS; CERVICAL CARCINOMA; CLINICAL RESPONSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DWELL POSITIONS; EXACT TESTS; EXTERNAL BEAM RADIATION THERAPY; HIGH-DOSE RATE BRACHYTHERAPY; INTERNATIONAL FEDERATION; KAPLAN-MEIER; LOCAL CONTROL; LOCAL FAILURE; OVERALL SURVIVAL; TANDEM AND OVOID; THREE DIMENSIONAL IMAGES; TREATMENT TECHNIQUES; TUMOR VOLUMES;

CHEMOTHERAPY; DISEASE CONTROL; IRIDIUM; ONCOLOGY; RADIOTHERAPY; THREE DIMENSIONAL; TUMORS;

TOXICITY;

BEVACIZUMAB; CARBOPLATIN; CELECOXIB; CISPLATIN; FLUOROURACIL; IRIDIUM 192; PACLITAXEL;

ACUTE TOXICITY; ADAPTIVE CERVICAL BRACHYTHERAPY; ADULT; AGED; ARTICLE; BLOOD TOXICITY; BLOOD VESSEL OCCLUSION; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; COLON PERFORATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECTOVAGINAL FISTULA; SKIN TOXICITY; SURVIVAL TIME; TREATMENT FAILURE; TUMOR REGRESSION; TUMOR VOLUME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER; UTERINE FUNDUS; VAGINA STENOSIS; VAGINITIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRIDIUM RADIOISOTOPES; NEOPLASM RECURRENCE, LOCAL; RECTUM; RETROSPECTIVE STUDIES; URINARY BLADDER; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; VAGINA;

EID: 76049119549     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.02.044     Document Type: Article

References (39)

1. Beadle B.M., Jhingran A., Salehpour M., et al. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 73 (2009) 235-241
2. Lee C.M., Shrieve D.C., and Gaffney D.K. Rapid involution and mobility of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 58 (2004) 625-630
3. Lin L.L., Yang Z., Mutic S., et al. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys 65 (2006) 177-181
4. Mayr N.A., Taoka T., Yuh W.T., et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 52 (2002) 14-22
5. Nam H., Park W., Huh S.J., et al. The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 107 (2007) 320-325
6. Haie-Meder C., Potter R., Van Limbergen E., et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 74 (2005) 235-245
7. Potter R., Haie-Meder C., Van Limbergen E., et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78 (2006) 67-77
8. Ohara K., Nemoto K., Ohnishi K., et al. Classical tandem-source dwelling covering the entire uterus: Essential in modern intracavitary radiotherapy for cervical cancer?. Radiat Med 25 (2007) 386-392
9. Leborgne F., Fowler J.F., Leborgne J.H., et al. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Radiat Oncol Investig 5 (1997) 289-299
10. Chen S.W., Liang J.A., Yang S.N., et al. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 67 (2003) 69-76
11. Chung Y.L., Jian J.J., Cheng S.H., et al. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: A phase I/II study. Gynecol Oncol 97 (2005) 126-135
12. Eifel P.J., Winter K., Morris M., et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22 (2004) 872-880
13. Kim Y.S., Shin S.S., Nam J.H., et al. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol 108 (2008) 195-200
14. Novetsky A.P., Einstein M.H., Goldberg G.L., et al. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer. Gynecol Oncol 105 (2007) 635-640
15. Ozsaran Z., Kamer S., Yalman D., et al. Treatment results and prognostic factors for cervical cancer patients treated by radiochemotherapy with weekly cisplatin. Eur J Gynaecol Oncol 28 (2007) 196-200
16. Potter R., Dimopoulos J., Bachtiary B., et al. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up. Radiother Oncol 79 (2006) 80-86
17. Rose P.G., Ali S., Watkins E., et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: A Gynecologic Oncology Group Study. J Clin Oncol 25 (2007) 2804-2810
18. Shakespeare T.P., Lim K.H., Lee K.M., et al. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: Is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?. Int J Gynecol Cancer 16 (2006) 277-282
19. Souhami L., Seymour R., Roman T.N., et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 27 (1993) 871-878
20. Toita T., Moromizato H., Ogawa K., et al. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. Gynecol Oncol 96 (2005) 665-670
21. Tseng C.J., Chang C.T., Lai C.H., et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 66 (1997) 52-58
22. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
23. Ozsaran Z., Yalman D., Yurut V., et al. Radiochemotherapy for patients with locally advanced cervical cancer: Early results. Eur J Gynaecol Oncol 24 (2003) 191-194
24. Chen S.W., Liang J.A., Hung Y.C., et al. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: A control cohort comparison with radiation alone on treatment outcome and complications. Int J Radiat Oncol Biol Phys 66 (2006) 1370-1377
25. Eifel P.J., Moughan J., Erickson B., et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: A patterns of care study. Int J Radiat Oncol Biol Phys 60 (2004) 1144-1153
26. Perez C.A., Grigsby P.W., Lockett M.A., et al. Radiation therapy morbidity in carcinoma of the uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44 (1999) 855-866
27. Ferrigno R., dos Santos Novaes P.E., Pellizzon A.C., et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications. Int J Radiat Oncol Biol Phys 50 (2001) 1123-1135
28. Clark B.G., Souhami L., Roman T.N., et al. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 38 (1997) 989-993
29. Ogino I., Kitamura T., Okamoto N., et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys 31 (1995) 725-734
30. Toita T., Kakinohana Y., Ogawa K., et al. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Analysis of dose and fractionation schedule. Int J Radiat Oncol Biol Phys 56 (2003) 1344-1353
31. Fellner C., Potter R., Knocke T.H., et al. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 58 (2001) 53-62
32. Dewitt K.D., Hsu I.C., Speight J., et al. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1270-1274
33. Potter R., Dimopoulos J., Kirisits C., et al. Recommendations for image-based intracavitary brachytherapy of cervix cancer: The GYN GEC ESTRO Working Group point of view: In regard to Nag, et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172). Int J Radiat Oncol Biol Phys 62 (2005) 293-295 author reply 295-296
34. Kirisits C., Potter R., Lang S., et al. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62 (2005) 901-911
35. Saarnak A.E., Boersma M., van Bunningen B.N., et al. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. Radiother Oncol 56 (2000) 37-42
36. Schoeppel S.L., LaVigne M.L., Martel M.K., et al. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 28 (1994) 277-283
37. van den Bergh F., Meertens H., Moonen L., et al. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 47 (1998) 85-90
38. Wachter-Gerstner N., Wachter S., Reinstadler E., et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: Comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 68 (2003) 269-276
39. Michalski J.M., Purdy J.A., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 46 (2000) 391-402